Literature DB >> 26419284

Pancreatic Cancer: Promises and Failures of Target Therapies.

Francesca Aroldi, Paola Bertocchi, Edoardo Rosso, Tiziana Prochilo, Alberto Zaniboni1.   

Abstract

Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.

Entities:  

Mesh:

Year:  2016        PMID: 26419284     DOI: 10.2174/1574887110666150930122720

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  2 in total

Review 1.  B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma.

Authors:  Claudia Minici; Sabrina Testoni; Emanuel Della-Torre
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

2.  The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer.

Authors:  Lingyu Hu; Haokai Xu; Xiaoguang Wang; Bin Wu; Fei Chen; Wei Chen; Yong Gao; Zhengxiang Zhong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.